Cardiovascular outcomes trials in type 2 diabetes
Reuters has already highlighted that physician trust and product quality will shape long-term winners in Indias crowded semaglutide market, especially as more than 50 brands begin to compete
Very low carbohydrate (ketogenic) diets in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Specifically: targeted lipolysis support in patients who are already exercising, already eating well, already on hormone replacement if indicated, and who have stubborn pockets of fat (abdominal, flank, dorsocervical) that aren't responding to the rest of the protocol
If someone is unable to take a medication orally, for example, these pharmacies could create a compounded version as a cream or intravenous (IV) drip, King explains
Oncogenic activation of PI K3 CA in cancers: Emerging targeted therapies in precision oncology